All posts
-
Control Station Accelerates Global Expansion with Acquisition
Control Terminal has actually introduced the effective purchase and assimilation of its Ireland-based joint endeavor and circulation companion.
-
HANNOVER: Battery Cell and Pack Production for Electric Mobility
At the upcoming HANNOVER MESSE, 11 business will collectively offer the “Battery Cell Manufacturing” job.
-
MSD invests USD 1bn to expand US vaccine production
The brand-new manufacturing growth marks “a considerable turning point” in reinforcing production capability in the United States, according to MSD’s head of prod…
-
Billion-dollar deal offers additional opportunity – but Zealand Pharma CEO maintains focus on crown jewel
Zealand Pharma can not have actually requested a far better companion than Roche, claims chief executive officer Adam Steensberg.
-
Reactions to EU critical medicines plan are pouring in – regional joint procurement groups delighted
The Danish pharmaceutical market invites the European Payment’s strategies to enhance the continent’s very own supply chains for life-saving medications, yet the strate…
-
Novo Nordisk stock halved since peak: Lost USD 336bn in market capitalization
The Novo Nordisk share cost came to a head at the end of June in 2015.
-
EU Commission builds on COVID-19 pandemic experience: Proposes joint procurement of critical medicines
Even more and far better financial investment in vital medications is required, states the European Payment in a brand-new proposition to allow a joint public purchase.
-
Zealand Pharma enters obesity collaboration with Roche and gets USD 1.4bn in cash
The contract concerns the excessive weight prospect petrilintide.
-
Abbvie will test monthly dose of Gubra’s weight-loss candidate
Abbvie’s head of research study claims the business is open to various other alternatives in weight problems therapies.
-
Compounders suffer defeat in Eli Lilly copycat drug case
Compounders have actually filed a claim against the FDA over the choice to get rid of Eli Lilly and Novo Nordisk’s hit medicines from the firm’s scarcity checklist. Cur…
